Neurodiagnostics Market Size, Share, Growth Analysis, By Condition(Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders), By End User(Hospitals & Surgery Centers, Diagnostic Laboratories & Imaging Centers, Neurology Centers, and Others), By Region - Industry Forecast 2025-2032

Revenue share of the market in 2023 was occupied by North America with a dominating share of 35.8%. Many factors, such as a mature healthcare infrastructure, research and development initiatives, and health expenditures, contribute to this regional dominance. For instance, the 159-bed Indiana NeuroDiagnostic Institute and Advanced Treatment Center, NDI, which costs USD 120 million, opened in March 2019. Traumatic brain injury, neurodegenerative disorders such as Alzheimer's disease, acute and chronic mental illness, among others, are treated by the institution. Neurological conditions also happen to be relatively prevalent in the region; therefore, the more pressing need for neurodiagnostic arises.  

The European market in neurodiagnostic was found to be a lucrative space within this field. The market is growing due to the increasing prevalence of neurological conditions and the growing emphasis on timely detection and treatment. About 165 million Europeans suffer from a brain condition, and one in three people is estimated to experience a neurological or mental illness at any point during life, the European Commission announced in statistics it released recently. The growing incidence of neurological diseases is leading to the development and introduction of new and innovative brain imaging solutions, which in turn is expected to drive market growth. For instance, Hyperfine, Inc. recently received the CE mark for its portable MR imaging device, the Swoop, intended for brain imaging in February 2023.